Evidence map›Paper›PMID 16760571›Full record

ReviewImmunologic research2006

Development, migration, and survival of mast cells.

Yoshimichi Okayama, Toshiaki Kawakami

Open access · greenAbstract readReview
In one paragraph

Review in Immunologic research, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 168 papers.

0numbers the graph read from it
0cells of the map it votes in
168citing papers in PubMed
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

168 citing papers in PubMed, 415 citations in OpenAlex.

  1. iScience · 2026
    Article
  2. Mast Cells in the Developing Brain.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Review
  3. Review
  4. Review
  5. Emerging Therapies for Anaphylaxis.Immunology and allergy clinics of North America · 2026
    Review
  6. Article
  7. Article
  8. Mast cell driven immunometabolism as a therapeutic entry point in ESCC.Frontiers in cell and developmental biology · 2026
    Review
  9. Mast cells and wound healing: Still an open question.Histology and histopathology · 2025
    Review
  10. Review
  11. Article
  12. Immunopathogenesis of urticaria: a clinical perspective on histamine and cytokine involvement.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Review
  13. Role of Mast Cells in Eosinophilic Gastrointestinal Diseases.Immunology and allergy clinics of North America · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Research Advances in Mast Cell Biology and Their Translation Into Novel Therapies for Anaphylaxis.The journal of allergy and clinical immunology. In practice · 2023
    Review
  19. Review
  20. Article

108 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Yoshimichi OkayamaResearch Unit for Allergy Transcriptome, Research Center for Allergy and Immunology, RIKEN Yokohama Institute, Yokohama, Japan.
Toshiaki Kawakami
La Jolla Institute for Immunology · USRIKEN Center for Integrative Medical Sciences · JP

Funding

IgE Regulation of Mast Cell Growth and SurvivalR01AI050209 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI KAWAKAMI, TOSHIAKI · 2002 to 2006
$2.3M
ROLES OF PH DOMAINS IN MAST CELL SIGNAL TRANSDUCTIONR01AI038348 · NIAID · LA JOLLA INST FOR ALLERGY &IMMUNOLGY · PI KAWAKAMI, TOSHIAKI · 1996 to 2005
$1.3M
NIAID NIH HHS AI38348NIAID NIH HHS AI50209NIAID NIH HHS R01 AI038348NIAID NIH HHS R01 AI050209
6 · The paper itself

Abstract

Mast cells play a pivotal role in immediate hypersensitivity and chronic allergic reactions that can contribute to asthma, atopic dermatitis, and other allergic diseases. Because mast cell numbers are increased at sites of inflammation in allergic diseases, pharmacologic intervention into the proliferation, migration, and survival (or apoptosis) of mast cells could be a promising strategy for the management of allergic diseases. Mast cells differentiate from multipotent hematopoietic progenitors in the bone marrow. Stem cell factor (SCF) is a major chemotactic factor for mast cells and their progenitors. SCF also elicits cell-cell and cell-substratum adhesion, facilitates the proliferation, and sustains the survival, differentiation, and maturation, of mast cells. Therefore, many aspects of mast cell biology can be understood as interactions of mast cells and their precursors with SCF and factors that modulate their responses to SCF and its signaling pathways. Numerous factors known to have such a capacity include cytokines that are secreted from activated T cells and other immune cells including mast cells themselves. Recent studies also demonstrated that monomeric IgE binding to FcepsilonRI can enhance mast-cell survival. In this review we discuss the factors that regulate mast cell development, migration, and survival.

Indexed as

Cell DifferentiationCell MovementCell SurvivalAnimalsAutocrine CommunicationCytokinesGrowth SubstancesHematopoietic Stem CellsHumansHypersensitivityImmunoglobulin EInflammationMast CellsReceptors, IgEStem Cell FactorCytokinesGrowth SubstancesImmunoglobulin EReceptors, IgEStem Cell Factor

Identifiers

PMID16760571
PMCPMC1490026
OpenAlexW2036611467

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.